AlphAIAlphAI — Financial news for AI agents
rttnews.com$OMDA

Omada Turns $6 Mln Profit In Q3 And Ups 2026 Guidance; Shares Fall Over 20%

Omada Health (OMDA) reported Q3 2026 net income of $6.55M, up from a loss in 2025, driven by revenue growth to $91.31M. Adjusted EBITDA rose to $12.38M. The company raised 2026 revenue guidance to $344M-$346M and adjusted EBITDA to $32M-$34M. Shares fell 20.37% on Friday.

Original reporting
rttnews.com
Published Nov 6, 2026, 9:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 9:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$OMDA
Bearish
high confidence
Mentioned
$OMDA
Relevance
7/10
AlphAI data visualization · based on rttnews.com
Decision brief

The 30-second read

$OMDABearishMed
01

Why it matters

The earnings release and guidance upgrade are new information, causing a sharp sell‑off; investors may reassess valuation.

02

Market read

First‑report earnings and guidance for a micro‑cap health‑tech firm, driving immediate price action.

03

What to watch

Cash balance of $243M provides runway; AI-enabled platform may drive future margin expansion.

Relevance 7/10Novelty 7/10Timing: after-hours today

Background

Omada Health reported Q3 2026 results, turning a profit and raising full-year revenue guidance, while its stock fell 20% on the announcement.

Company-level read

Ticker impact

$OMDABearishHigh confidence
Context

Q3 earnings report shows profit and raised 2026 guidance, while shares fell over 20% on the news.

Expected impact

downward pressure as market prices in the guidance and large intraday sell-off

Evidence & confidence

The article is the first disclosure of the earnings and guidance; the 20% price drop indicates immediate market reaction.

Market effects

Sector

Highlights growing demand for digital health platforms, may boost peers in telehealth.

Regional

Limited to US-listed health-tech stocks.

Global

Modest; primarily affects investors in US digital health sector.

Counterpoint

What could challenge this read

Profitability and member growth could support a rebound if guidance is met.

Key entities

  • company
    Omada Health Inc.

    US‑listed digital health provider (NASDAQ: OMDA).

Read at source← All news

StoryOmada Health posts Q3 profit, raises 2026 guidance and announces CEO transition

Also covered by

1 outlet

Related articles

$OMDAMed

What Omada Health (OMDA) Said on Its Q3 Earnings Call

Omada Health (OMDA) expects Q4 revenue to decline due to seasonal factors, with adjusted EBITDA also moderating. The company ended Q3 with $243M in cash and no debt. CEO Sean Duffy will transition to executive chair in 2027, with Shao taking over as CEO. Omada's GLP-1 Care Track showed a 6% average weight loss at 12 weeks, according to peer-reviewed research.

finance.yahoo.com
$OMDAMedAI 8/10

Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership

Omada Health Inc (OMDA) reported record revenue and membership growth in Q3 2026. However, new enrollments are expected to decline in Q4 due to seasonality and tough comparisons. GLP-1 market dynamics and rising healthcare costs create uncertainty for 2027. Adjusted EBITDA is expected to moderate due to increased R&D and staffing. The company aims for 20%+ growth in 2027 through expanding covered lives, improving enrollment rates, and increasing engagement.

finance.yahoo.com
$OMDAMed

Omada Health Reports Third Quarter 2026 Results

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Third Quarter 2026 Results • Quarterly Revenue of $91 million and All-Time High Total Members of 1.1 million • Revenue Grew 34% and Total Members Increased 36% Year over Year • Raises Full Year 2026 Financial Outlook SAN FRANCISCO - November 5, 2026 - Omada H

SEC EDGAR 8-K
$OMDALowAI 8/10

Omada Health reports weight loss study results for GLP-1 program

Omada Health (NASDAQ:OMDA) presented a 12-week study at the World Obesity and Weight Management Congress, showing its GLP-1 Care Track program led to 6.0% average weight loss vs. 3.3% for usual care. The study, published in Diabetes, Obesity and Metabolism, involved 245 adults with obesity. Omada's program also improved body composition, well-being, and reduced depression/anxiety symptoms.

investing.com